Skip directly to content

TAGline 2003

December 2003

November 2003

  • Lexiva Launch: Glaxo Makes Aggressive Push Into Protease Market With New and Improved Amprenavir
  • Scrambling the Code: What a Difference a Nucleotide Makes -- Plus IL-15's Role Is STI Outcomes

October 2003

September 2003

July 2003

  • Saturation Point: Latest Licensure Breaks Records for Ho-Hum Reception, yet What Exactly Is There to Be Excited About?
  • Wheat from Chaff: Take-No-Prisoners Tack on TAG Pipeline Report Snubs Host of Drab Wannabes; Cozies up to Fevered Few

June 2003

May 2003

April 2003

  • Full Count: Having Sired Twin Failures Hivid and Invirase, Roche Tempts Fate With High Profile T-20 Launch
  • Tipping Point: MSF, Oxfam Redefine the Possible, and Y2K Activist Trek to Durban Marks a Watershed
  • TAG at Ten: The Year 2001

March 2003

  • Under Icebergs' Tip: Tissue T-Cell Analysis Represents Renewed Challenge to "Tap and Drain" Orthodoxy
  • Yin and Yang: Yokohama, Vancouver, Twin Pacific Ports, Serve as Polar Opposites for Scientific Advances
  • Consensus Statement: AIDSVAX Fails to Protect; VaxGen's Claims of Efficacy in Black and Asian Participants Are Misleading and Premature
  • Magic With Numbers: AIDSVAX Arbitrary and Post-Hoc Subset Analysis, Up Close
  • TAG at Ten: The Year 2000

January/February 2003